AI Verdict
KPEA has stronger fundamentals based on our AI analysis.
KPHMW vs KPEA Fundamental Comparison
| Metric | KPHMW | KPEA |
|---|---|---|
| Revenue | $0.0 | $174,824.0 |
| Net Income | $-10.8M | $-265,577.0 |
| Net Margin | N/A | -151.9% |
| ROE | -67.2% | N/A |
| ROA | -44.7% | -26.4% |
| Current Ratio | 5.99x | 0.06x |
| Debt/Equity | 0.02x | N/A |
| EPS | $-2.64 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KPHMW vs KPEA: Frequently Asked Questions
Is KPHMW or KPEA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KPEA has stronger fundamentals. KPHMW is rated STRONG SELL (78% confidence) while KPEA is rated STRONG SELL (95% confidence). This is not investment advice.
How does KPHMW compare to KPEA fundamentally?
KIORA PHARMACEUTICALS INC has ROE of -67.2% vs Kun Peng International Ltd.'s N/A. Net margins are N/A vs -151.9% respectively.
Which stock pays higher dividends, KPHMW or KPEA?
KPHMW has a dividend yield of N/A or no dividend while KPEA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KPHMW or KPEA for long term?
For long-term investing, consider that KPHMW has STRONG SELL rating with 78% confidence, while KPEA has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KPHMW vs KPEA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KPHMW vs KPEA, the AI consensus favors KPEA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.